|
| |
BioPortfolio's Approved Drugs DatabaseVancomycinVancomycin HydrochlorideDownload PDF containing detailed information.
Press Releases About Vancomycin:
|
 |
| BD Completes Acquisition of HandyLab, Inc. |
20th November, 2009 |
BD (Becton, Dickinson and Company) |
FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) today announced the completion of its acquisition of HandyLab, Inc., an Ann Arbor, Michigan-based
|
| BD Announces Agreement to Acquire HandyLab, Inc. |
23rd October, 2009 |
BD (Becton, Dickinson and Company) |
FRANKLIN LAKES, N.J., Oct. 23 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it signed a definitive agreement to acquire HandyLab, Inc., an Ann Arbor,
|
| Optimer Pharmaceuticals Announces Presentations of Additional Data From the Fidaxomicin North American Phase 3 Trial at Upcoming IDSA Annual Meeting |
19th October, 2009 |
Optimer Pharmaceuticals, Inc. |
SAN DIEGO, Oct. 19 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) announced that additional data related to fidaxomicin, the Company's lead developmental product candidate
|
| Reportlinker Adds Who's Doing What in Molecular Diagnostics? - Kalorama / Emmes Survey of US Laboratories Report |
24th September, 2009 |
Reportlinker |
-- Communicable Diseases - CMV (Cytomegalovirus), EBV (Epstein-Barr Virus),
Group B Strep, Enterovirus
What Labs Do Now, What They are Planning in the Future
There has been much analysis
|
| Trius' Torezolid Antibiotic for the Treatment of Severe Skin Infections Featured at ICAAC Meeting |
12th September, 2009 |
Trius Therapeutics, Inc. |
-- L1-335/355: Safety and Efficacy of TR-701 in a Phase 2 Randomized,
Double-Blind Study in Patients with Severe Complicated Skin and Skin
Structure Infections (cSSSI)
(Poster
|
Companies working in the area of Vancomycin from Bioportfolio's Biocorporate database : | |
| Company Name | |
Cubist Pharmaceuticals Incorporated is a drug company focused on the discovery, development and commercialization of novel drugs to treat infections. Daptomycin, the Company's in-licensed lead product...
www.cubist.com/ View full profile
| |
AdvanDx announces that at the recent American Society for Microbiology (ASM) meeting in Orlando, Florida, EVIGENE™ kits for detecting specific antibiotic resistance, virulence, and toxicity markers...
www.advandx.com/ View full profile
| |
With 2005 revenue of nearly $1.7 billion, Dade Behring is the world's largest company dedicated solely to clinical diagnostics. It offers a wide range of products, systems and services designed to...
www.dadebehring.com View full profile
| | →View more Vancomycin related companies. |
This page has been viewed 39 times
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Vancomycin across BioPortfolio, or for Vancomycin Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
